Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.



Status:Completed
Conditions:Angina, Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - Any
Updated:2/2/2019
Start Date:February 2014
End Date:August 2014

Use our guide to learn which trials are right for you!

Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting

This is a retrospective study, designed to be conducted at a single-center in the US. The
study will conduct a one-time data abstraction from approximately 500 patient medical charts
who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order
of the Principal Investigator. Limited demographic data and patient data pertaining to
cardiology referral or advanced diagnostic testing will be collected. All data will be
collected anonymously.

Though the diagnostic properties of Age/Sex/Gene Expression Score (ASGES) or Corus CAD have
been evaluated in previous observational studies, there are limited data regarding how
primary care clinicians are using the results of the test in the care and management of
patients with symptoms suggestive of angina in the African-America patient population. This
retrospective study is designed to examine the relationship between the Corus CAD (ASGES)
score and patterns of care regarding cardiology referral or further cardiac diagnostic
testing in an African-American patient population single-center site.

This is a retrospective study, designed to be conducted at a single-center in the US. The
study will conduct a one-time data abstraction from approximately 500 patient medical charts
who received Corus CAD (ASGES) testing, by order of the Principal Investigator. Limited
demographic data and patient data pertaining to cardiology referral or advanced diagnostic
testing will be collected. All data will be collected anonymously. IRB approval will be
requested with a waiver of informed consent, as no identifying information will be collected.

This retrospective study is designed to understand the patterns of care, including referrals
for cardiac care and testing (including referrals to a cardiologist, exercise stress testing,
cardiac computerized tomography angiography (CCTA), invasive cardiac angiography (ICA))
within an African-American patient population.

Inclusion Criteria:

- All patients receiving Corus CAD (ASGES) from 2008-2012.

Exclusion Criteria:

- If any of the following co-moribidities, medical conditions, or current medical
statuses are noted in the patient medical chart, s/he will be excluded from the
analysis dataset:

1. History of diabetes;

2. Revascularization or myocardial infarction;

3. Systemic infection or inflammatory condition; or

4. Use of steroids, immunosuppressive agents, or chemotherapeutic agents.
We found this trial at
1
site
8701 Old Troy Pike
Dayton, Ohio 45402
?
mi
from
Dayton, OH
Click here to add this to my saved trials